Maximising Impact of Prescription Drugs in Rheumatoid Arthritis

Projektinformationen

SQUEEZE

ID Finanzhilfevereinbarung: 101095052

DOI

10.3030/101095052

EK-Unterschriftsdatum 25 November 2022

Startdatum 1 Dezember 2022

Enddatum 30 November 2027

Finanziert unter

• Health

Gesamtkosten

€ 9 197 602,50

EU-Beitrag

€ 9 197 602,50

Koordiniert durch

MEDIZINISCHE UNIVERSITAET WIEN
Austria

CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.

Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.

Leistungen

Documents, reports (11)

Descriptive map of TTV values
Ethics and Governance framework

Building the framework for ethics and governance

First submission package of RA-DRUM trial
Report on Associations between serum drug levels and anti-drug antibodies and clinical outcomes
Report on Data platform, warehousing and data & script sharing
Updated Plan on dissemination, exploitation and communication (DEC) of results

This deliverable gives an overview of the planned DEC activities for the project- including planned events and activities, and a first version of communication documents and templates- and a collection of PPTs that can be used as a basis for presentation of Squeeze. The PPTs and templates collected on the Squeeze online portal (for consortium only) will be updated as needed. The report includes website implementation in a first version (including public information/PPTs) and social media (current plan is focusing on LinkedIn and Twitter) initiated.

Risk assessment Report, study monitoring will be carried out throughout the trial with end of study report

First submission package BioBest Trial

Report on SQUEEZE stakeholder strategy
Conclusions from the Kick-off Meeting

Summary reporting of Kick-off meeting

First submission package of MethMax trial; reporting of MTX responder dynamics

First submission package of MethMax trial and reporting of MTX responder dynamics to inform trial

Report with contextual analysis - Map of practice patterns of RA care, use of precision medicine approaches

Websites, patent fillings, videos etc. (1)

public web site